Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daclatasvir interaction study with atazanavir boosted by ritonavir versus cobicistat
NL-OMON42827Active, not recruiting
- Sponsor
- Apotheek
- Start
- Nov 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of daclatasvir, atazanavir, ritonavir and cobicistat in hepatitis C virus infection and human immunodeficiency virus infection (HIV), sponsored by Apotheek. Primary endpoints: Daclatasvir pharmacokinetics comparison and Atazanavir pharmacokinetics comparison. Started Nov 2015; status: active, not recruiting.
02
Drugs
daclatasviratazanavirritonavircobicistat
03
Conditions
hepatitis C virus infectionhuman immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NL-OMON42827.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON42827.